Cardiol Therapeutics Inc (CRDL)

Shares of Cardiol Therapeutics (CRDL) dropped by 6.76% from $0.74 to $0.69 in the trading on Friday, October 20, 2023. The reason why CRDL is down today is due to the company receiving a Nasdaq deficiency notice due to non-compliance with the minimum bid price requirement of US$1.00 per share. This notice has no immediate effect on CRDL's Nasdaq listing, and the company has until April 16, 2024, to regain compliance by maintaining a minimum bid price of US$1.00 per share for ten consecutive business days. If not achieved, there's a possibility of delisting from Nasdaq, but it doesn't impact CRDL's TSX listing.

Shares of Cardiol Therapeutics (CRDL) dropped by 13.45% from $1.19 to $1.03 in the trading on Tuesday, August 8, 2023. The reason why CRDL is down today is due to the company announcing on August 7, 2023, that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) ("Minimum Bid Requirement") for continued listing on The Nasdaq Capital Market. This compliance news has no apparent impact on the share price but may reflect broader market sentiment or other factors influencing investor behavior.